Governmental policies on HIV infection in China
被引量：4
Governmental policies on HIV infection in China
摘要
This article is a general review of the evolvement of HIV/AIDS-related public policies in China since 1980’s. It tracks the important laws, regulations and other governmental documents in regard to HIV/AIDS prevention mainly at central level.
参考文献15
-
1Regulations Concerning the Monitoring and Control of AIDS.Ministry of Health, China. 1988.
-
2Border and Quarantine Law. National People's Congress, People's Republic of China. 1986.
-
3Law of Infectious Diseases Prevention and Control. National People' s Congress, People's Republic of China. 1989.
-
4Methods of Implementation of the Law of Infectious Diseases Prevention and Control. Ministry of Health, China. 1991.
-
5Law of Infectious Diseases Prevention and Control. National People's Congress, People's Republic of China. Revision in August 2004.
-
6Law for Protection of Mother and Infant. National People's Congress, People's Republic of China. 1995.
-
7Notice for Promoting the Condom Use for HIV/AIDS Prevention and Control. State Council, People's Republic of China. 2004.
-
8Recommendations on Strengthening AIDS Prevention and Control.State Council, Ministry of Health, PRC. 1995.
-
9Law of Blood Donation. National People's Congress, People's Republic of China. 1997.
-
10Responsibilities of Ministries and Depaitments of State in AIDS Control and Prevention. State Council. People's Republic of China. 1997.
同被引文献20
-
1Na HE,Roger DETELS.The HIV epidemic in China: history, response, and challenge[J].Cell Research,2005,15(11):825-832. 被引量：17
-
2夏国美.中国艾滋病社会政策的推进与改革[J].探索与争鸣,2006(11):29-33. 被引量：16
-
3Sarah Larney,Kate Dolan.Compulsory detoxification is a major challenge to harm reduction in China[J].International Journal of Drug Policy.2009(3)
-
4Bradley M Mathers,Louisa Degenhardt,Benjamin Phillips,Lucas Wiessing,Matthew Hickman,Steffanie A Strathdee,Alex Wodak,Samiran Panda,Mark Tyndall,Abdalla Toufik,Richard P Mattick.Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review[J].The Lancet.2008(9651)
-
5Theodore M.Hammett,ZunyouWu,Tran TienDuc,DavidStephens,SheenaSullivan,WeiLiu,YiChen,DoanNgu,Don C.Des Jarlais.‘Social evils’ and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam[J].Addiction.2007(1)
-
6Nguyen Tran Hien,Le Truong Giang,Phan Nguyen Binh,I. Wolffers.The social context of HIV risk behaviour by drug injectors in Ho Chi Minh City, Vietnam[J].AIDS Care.2000(4)
-
7Vu Minh Quan,A. Chung,Abu S. Abdul-Quader.The Feasibility of a Syringe-Needle-Exchange Program in Vietnam[J].Substance Use & Misuse.1998(5)
-
8李太生.中国艾滋病抗病毒治疗：成功与挑战[J].中华医学杂志,2009,89(13):865-866. 被引量：9
-
9王霞,丁心平,苏斌,徐臣,刘媛,张言敏,祝军玲,韩丽涛,阮玉华,邵一鸣.安徽省既往献血员HIV感染后生存时间和抗病毒治疗效果研究[J].中华流行病学杂志,2009,30(11):1135-1138. 被引量：3
-
10豆智慧,赵燕,何云,何文生,计国平,徐臣,马烨,赵德才,于兰,张福杰.免费抗病毒治疗降低获得性免疫缺陷综合征患者病死率回顾性队列研究[J].中华预防医学杂志,2009,43(12):1091-1095. 被引量：46
引证文献4
-
1秋旺,罗伯特.阿里,西蒙.巴德温,斯蒂芬.米尔萨,陆思羽,张晓春.越南毒品政策:变化中的十年[J].广西警官高等专科学校学报,2014,27(6):49-59.
-
2刘倩萍,张万里,邓丽春,段元会,姚芝梅,高旭东,邓瑾,宋本莉,张恒,梁姝,秦光明,阮玉华.四川省西昌市艾滋病抗病毒治疗死亡分析[J].预防医学情报杂志,2015,31(8):595-599. 被引量：3
-
3何耀祖,陈晓婷,陈景良,郭朋乐,李凌华.我国艾滋病抗病毒治疗药物变迁及进展[J].广东医学,2023,44(2):157-160. 被引量：6
-
4Yanli Liu,Yurong Zhang,Xiaoxin Xu,Zhidi Deng,Xiaobo Wang,Duozhen Yuan,Zelin Xue,Xiulan Zhang.Preventing HIV Epidemic in China:Policy Evolution and Coordination Mechanisms in the Past Four Decades[J].China CDC weekly,2023,5(48):1084-1091.
二级引证文献9
-
1陈曦,李珊,谢渝中,吴国辉,张丽杰.重庆市推迟申请抗病毒治疗的HIV感染者特征分析及干预[J].预防医学情报杂志,2015,31(12):988-992.
-
2宋本莉,张翔,边会珍,殷俊,姜正清,梁姝,邢辉,杨小艺,阮玉华.四川省西昌市2008—2018年初始抗病毒治疗HIV感染者死亡和脱失情况[J].中国热带医学,2019,19(12):1113-1118. 被引量：11
-
3丁彧,曾祥荣,朱艳燕,郑洪,韩丽涛,陈礼,阮玉华.江苏省丹阳市2005—2020年初始抗病毒治疗HIV感染者死亡和脱失情况[J].中国热带医学,2021,21(7):628-632. 被引量：3
-
4郑鸽之,杨鑫,刘小静,张靓,任艳叶.西安地区接受抗病毒治疗的HIV感染者/AIDS患者服药依从性调查分析[J].华南预防医学,2023,49(4):514-517. 被引量：2
-
5孙雪晴,王亚楠,张海燕,徐立然,Alan Wang,李青雅.后ART时代艾滋病治疗面临的挑战与展望[J].中国皮肤性病学杂志,2024,38(6):656-662.
-
6陈秀静,苏菲菲,郑永乐,郑琼娜.艾滋病患者FOXP3、CXCR5、TGF-β1和T淋巴细胞亚群及其对预后的预测价值[J].中华医院感染学杂志,2024,34(11):1601-1605.
-
7王海艳.艾滋病患者焦虑抑郁情绪、细胞免疫指标及对治疗反应性影响的交互作用分析[J].哈尔滨医药,2024,44(3):66-69.
-
8孙思曼,江海燕,范潇予,李万芳,包捷,王川,靳洪涛.抗获得性免疫缺陷综合征复方制剂研究进展[J].中国药物警戒,2024,21(9):978-984.
-
9刘天美,杜晓琳,雍小兰.洛匹那韦利托那韦片在中国健康志愿者中的生物等效性和安全性研究[J].中国新药杂志,2024,33(20):2143-2148.
-
1何晓敏.HIV改变DNA引起罕见癌症[J].中国国境卫生检疫杂志,1994,17(E04):62-62.
-
2新的HIV疫苗正进行早期动物实验[J].中华医学信息导报,2003,18(2):12-12.
-
3李冰.拉米夫定每天一次与每天两次使用的比较[J].传染病网络动态,2004(10):14-14.
-
4刘智勇,单书香,刘林.国外抗爱滋病天然产物研究近况[J].天然产物研究与开发,1994,6(4):85-90. 被引量：7
-
5林鹏,刘勇鹰,王晔,付笑冰,许锐恒,万卓越,颜瑾,赵茜茜.Survey of HIV Infection among Injection Drug Users in Guangdong, China[J].Chinese Journal of Sexually Transmitted Infections,2005,5(1):5-9. 被引量：1
-
6梁书奇,吴小梅,陈姝华,蔡颖.流动人口肺结核患者43例的临床[J].临床肺科杂志,1998,3(4):57-57. 被引量：1
-
7王国荣.舟山市普陀区人群HIV/AIDS流行现状[J].浙江预防医学,2005,17(12):20-20. 被引量：3
-
8匹格列酮改善HAART引起的HIV患者代谢综合征[J].传染病网络动态,2005(4):9-9.
-
9王颖,李文华.菏泽市2004年HIV感染监测结果分析[J].中国麻风皮肤病杂志,2005,21(8):656-656. 被引量：1
-
10新喋呤水平预测晚期HIV-1感染的疾病进展[J].传染病网络动态,2005(4):9-10.
